These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 7946101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [Abstract] [Full Text] [Related]

  • 3. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
    AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
    [Abstract] [Full Text] [Related]

  • 4. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
    Anderson RE, Lang W, Shiboski S, Royce R, Jewell N, Winkelstein W.
    Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
    [Abstract] [Full Text] [Related]

  • 5. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.
    Hofmann B, Wang YX, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL.
    AIDS; 1990 Mar; 4(3):207-14. PubMed ID: 1972020
    [Abstract] [Full Text] [Related]

  • 6. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
    Schwartländer B, Bek B, Skarabis H, Koch J, Burkowitz J, Koch MA.
    AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
    [Abstract] [Full Text] [Related]

  • 7. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [Abstract] [Full Text] [Related]

  • 8. HIV infection in women: immunological markers and the influence of pregnancy.
    Brettle RP, Raab GM, Ross A, Fielding KL, Gore SM, Bird AG.
    AIDS; 1995 Oct; 9(10):1177-84. PubMed ID: 8519455
    [Abstract] [Full Text] [Related]

  • 9. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA, Ferreccio C, Abarca K, Ortiz E, Noriega M, Pérez C, Labarca J, Torres M, Ferrés M, González C, Acuña G.
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [Abstract] [Full Text] [Related]

  • 10. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.
    AIDS; 1992 Apr; 6(4):421-6. PubMed ID: 1616637
    [Abstract] [Full Text] [Related]

  • 11. Use of monitored CD4 cell counts: predictions of the AIDS epidemic in Scotland: CD4 Collaborative Group.
    AIDS; 1992 Feb; 6(2):213-22. PubMed ID: 1348418
    [Abstract] [Full Text] [Related]

  • 12. [Discriminative value for AIDS case of erythrocyte sedimentation rate, immunoglobulins IgA and IgM, and beta 2-microglobulin in combination with the CD4+ lymphocyte count].
    Pérez de Oteyza C, Menéndez Martínez MA, Muro García R, Pérez Aznar C, Barberán López J.
    An Med Interna; 1998 Aug; 15(8):411-4. PubMed ID: 9780421
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV.
    N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.
    Vanhems P, Lambert J, Guerra M, Hirschel B, Allard R.
    J Infect Dis; 1999 Dec 18; 180(6):1803-8. PubMed ID: 10558934
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M.
    J Biol Regul Homeost Agents; 2003 Dec 18; 17(2):191-4. PubMed ID: 14518722
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC, Drummond JE, Vaidya K, Mann DL, Eyster ME.
    N Engl J Med; 1989 Oct 26; 321(17):1141-8. PubMed ID: 2477702
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
    Santagostino E, Gringeri A, Cultraro D, Tradati F, Siracusano L, Marinoni A, Mannucci PM.
    Cell Mol Biol (Noisy-le-grand); 1995 May 26; 41(3):371-80. PubMed ID: 7580830
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.